NCT05256602

Brief Summary

Numerous scientific agencies and iraqi MOH has advised to promote population vaccination as an attempt to reduce the burden of COVID19. The aim of our study is to evaluate knowledge, Attitude, practice and concerns toward different type of covid19 vaccine of Iraqi population. This will help us concentrate our efforts to increase Willingness of vaccination among southren Iraqi people

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 25, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

March 7, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

February 25, 2022

Status Verified

February 1, 2022

Enrollment Period

2 months

First QC Date

February 24, 2022

Last Update Submit

February 24, 2022

Conditions

Keywords

Vaccine

Outcome Measures

Primary Outcomes (1)

  • KAPC knowledge, Attitude, Practice and Concerns questionnaire

    How vaccination and other attitudes are affected by COVID

    at the time of survey and upto 2 months

Secondary Outcomes (1)

  • Factors associated with participants refusing the vaccination

    at the time of survey and upto 2 months

Study Arms (1)

survey respondant

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults above 18 years old living in southern Iraq.

You may qualify if:

  • Willingness to participate in the study
  • Living in southern Iraq

You may not qualify if:

  • Less than18 years
  • Not willing to complete the questionnaire
  • Unable to complete the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Alhasan M Al-Mudhaffe, BCPS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2022

First Posted

February 25, 2022

Study Start

March 7, 2022

Primary Completion

May 1, 2022

Study Completion

July 1, 2022

Last Updated

February 25, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

IPD can be shared with a suitable request from other researchers

Shared Documents
STUDY PROTOCOL, SAP